News – Page 935 – Endpoints News

Alkermes adds bipolar I disorder to its FDA wishlist; Congo confirms first Ebola case in large city

6 years ago

Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups

6 years ago

Boehringer buys Swiss biotech in its latest M&A deal, going the next-gen cancer vaccine route

6 years ago

AbbVie beefs up the oncology pipeline, bagging an upstart STING player with its own unique approach

6 years ago

Billing itself as the first AI biotech to launch human trials, Recursion adds $121M C round

6 years ago

Eton Pharma handed CRL for reformulated conjunctivitis eye drop

6 years ago

FDA bats back AstraZeneca's SGLT diabetes drug for Type 1 diabetes — blocking a class on safety fears

6 years ago

GSK to tap Jonathan Symonds as chairman, leveraging Big Pharma experience for consumer biz deal

6 years ago

Hal Barron's team at GSK scores a win with positive Zejula PhIII frontline study — now comes the hard part

6 years ago

Gilead unleashes a $5B late-stage cash alliance with Galapagos — laying out O'Day's R&D strategy

6 years ago

Sofinnova lends AbiVax a hand for PhII anti-inflammatory trials, picking up €12M worth of stock

6 years ago

Reckitt Benckiser shells $1.4B to settle US probe; NICE backs diabetes, psoriasis treatments

6 years ago

Ex-DARPA director pursues all-in-one cancer pill as NED CEO; Karyopharm loses commercial chief ahead of drug rollout

6 years ago

ICER update on Duchenne drugs pushes up price estimates for Exondys 51, Emflaza ahead of July panel review

6 years ago

Supercharging CAR-T with cancer vaccine, MIT team spotlights some new tech underpinning Darrell Irvine's startup

6 years ago

Broad star Feng Zhang unveils a new CRISPR platform, editing RNA and eliminating Alzheimer's threat — in cells

6 years ago

FDA revises 1999 draft guidance on population pharmacokinetics

6 years ago

Amgen, Novartis scrap Alzheimer's studies — is BACE finally dead or will Biogen and Eisai carry on?

6 years ago

Fresh out of Eli Lilly, Christi Shaw surfaces as Daniel O'Day's new CEO at CAR-T pioneer Kite

6 years ago

Eli Lilly's Christi Shaw bows out of top post at the Bio-Medicines unit

6 years ago

No clear answers: Yes, recent actions against Chinese American scientists do pose a threat — but maybe those ...

6 years ago

Alnylam’s Maraganore switches ‘perhaps the best CFO in mid-cap biotech’ with Shire vet Jeff Poulton

6 years ago

After a radical downsizing, Teva beefs up US R&D campus; Tiaki recruits Suzanne Bruhn for the helm

6 years ago

Scripps-led consortium scores $129M NIH grant to work on vaccine for stubborn HIV

6 years ago

First page Previous page 932 933 934935936 937 938 Next page Last page